Edgestream Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-75,843	Closed	-$2.03M	–	1071
2024 Q2	$2.03M	Buy	+75,843	New	+$2.03M	0.1%	328
2023 Q4	–	Sell	-9,061	Closed	-$250K	–	1056
2023 Q3	$250K	Buy	9,061 +1,775	+24%	+$48.9K	0.02%	758
2023 Q2	$219K	Buy	+7,286	New	+$219K	0.02%	678